Ann Michelle Cunningham

Insider Reports History

Location
Downingtown, PA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ann Michelle Cunningham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 17,600 09 Sep 2025 Direct

Insider Reports Filed by Ann Michelle Cunningham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 09 Sep 2025 1 $0 4 Director 11 Sep 2025, 18:14
VTGN Vistagen Therapeutics, Inc. 06 Sep 2024 1 $0 4 Director 10 Sep 2024, 17:00
VTGN Vistagen Therapeutics, Inc. 04 Mar 2024 1 $0 4 Director 06 Mar 2024, 18:00
VTGN VistaGen Therapeutics, Inc. 01 Mar 2022 1 $0 4 CHIEF COMMERCIAL OFFICER, Director 03 Mar 2022, 15:15